z-logo
Premium
Extrapulmonary complications of COVID‐19: A multisystem disease?
Author(s) -
Zheng Kenneth I.,
Feng Gong,
Liu WenYue,
Targher Giovanni,
Byrne Christopher D.,
Zheng MingHua
Publication year - 2021
Publication title -
journal of medical virology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.782
H-Index - 121
eISSN - 1096-9071
pISSN - 0146-6615
DOI - 10.1002/jmv.26294
Subject(s) - medicine , pandemic , covid-19 , coronavirus , outbreak , disease , intensive care medicine , respiratory system , immunology , virology , pathology , infectious disease (medical specialty)
The outbreak of coronavirus disease 2019 (COVID‐19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), has been recently declared a pandemic by the World Health Organization. In addition to its acute respiratory manifestations, SARS‐CoV‐2 may also adversely affect other organ systems. To date, however, there is a very limited understanding of the extent and management of COVID‐19‐related conditions outside of the pulmonary system. This narrative review provides an overview of the current literature about the extrapulmonary manifestations of COVID‐19 that may affect the urinary, cardiovascular, gastrointestinal, hematological, hematopoietic, neurological, or reproductive systems. This review also describes the current understanding of the extrapulmonary complications caused by COVID‐19 to improve the management and prognosis of patients with COVID‐19.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here